The Miami Entrepreneur

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

Read Time:7 Second

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely. 

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post September home sales drop to lowest level since 2010
Next post Existing-home sales sink to a 14-year low, as home buyers pull back ahead of the November election